Early, Deep, And Durable Responses, And Low Rates Of Crs With Regn5458, A Bcmaxcd3 Bispecific Antibody, In A Phase 1/2 First-In-Human Study In Patients With Relapsed/Refractory Multiple Myeloma
REGN5458
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Early, Deep, And Durable Responses, And Low Rates Of Crs With Regn5458, A Bcmaxcd3 Bispecific Antibody, In A Phase 1/2 First-In-Human Study In Patients With Relapsed/Refractory Multiple Myeloma ### Output: REGN5458